Clinical Trials
3 trialsNCT02347228 2024-01-26
Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies
Oneness Biotech Co., Ltd.
Phase 1 Unknown
NCT04136834 2021-08-17
PT01
Athenex, Inc.
Phase 1 Unknown
NCT01024283 2009-12-02
Analysis of Pharmacodynamic Changes With AUY922A, an HSP90 Inhibitor
Royal Marsden NHS Foundation Trust
Unknown